Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
Open Access
- 1 April 2009
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 15 (4) , 552-560
- https://doi.org/10.3201/eid1504.081280
Abstract
In Europe, the 2007-08 winter season was dominated by influenza virus A (H1N1) circulation through week 7, followed by influenza B virus from week 8 onward. Oseltamivir-resistant influenza viruses A (H1N1) (ORVs) with H275Y mutation in the neuraminidase emerged independently of drug use. By country, the proportion of ORVs ranged from 0% to 68%, with the highest proportion in Norway. The average weighted prevalence of ORVs across Europe increased gradually over time, from near 0 in week 40 of 2007 to 56% in week 19 of 2008 (mean 20%). Neuraminidase genes of ORVs possessing the H275Y substitution formed a homogeneous subgroup closely related to, but distinguishable from, those of oseltamivir-sensitive influenza viruses A (H1N1). Minor variants of ORVs emerged independently, indicating multiclonal ORVs. Overall, the clinical effect of ORVs in Europe, measured by influenza-like illness or acute respiratory infection, was unremarkable and consistent with normal seasonal activity.Keywords
This publication has 29 references indexed in Scilit:
- Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South AfricaEmerging Infectious Diseases, 2008
- Fatal Oseltamivir-Resistant Influenza Virus InfectionNew England Journal of Medicine, 2008
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Antimicrobial Agents and Chemotherapy, 2008
- Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to OseltamivirPLoS Pathogens, 2008
- The war against influenza: discovery and development of sialidase inhibitorsNature Reviews Drug Discovery, 2007
- Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In VivoJournal of Virology, 2007
- Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their UseAntimicrobial Agents and Chemotherapy, 2006
- Implementation of the Community Network of Reference Laboratories for Human Influenza in EuropeJournal of Clinical Virology, 2005
- Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and OseltamivirAntimicrobial Agents and Chemotherapy, 2003
- Surveillance and impact of influenza in EuropeVaccine, 1999